Literature DB >> 24881942

Abnormalities in airway epithelial junction formation in chronic obstructive pulmonary disease.

Irene H Heijink1, Jacobien A Noordhoek, Wim Timens, Antoon J M van Oosterhout, Dirkje S Postma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24881942     DOI： 10.1164/rccm.201311-1982LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  37 in total

1.  Airway Basal stem/progenitor cells have diminished capacity to regenerate airway epithelium in chronic obstructive pulmonary disease.

Authors:  Michelle R Staudt; Lauren J Buro-Auriemma; Matthew S Walters; Jacqueline Salit; Thomas Vincent; Renat Shaykhiev; Jason G Mezey; Ann E Tilley; Robert J Kaner; Melisa W Y Ho; Ronald G Crystal
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

2.  Reply: Epithelial-Mesenchymal Transition: A Necessary New Therapeutic Target in Chronic Obstructive Pulmonary Disease?

Authors:  Jing Yang; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

3.  Novel insights into the effects of cigarette smoke on the airway epithelial surface-lessons learned at the European Respiratory Society International Congress 2018 in Paris.

Authors:  Gimano D Amatngalim; Rodolfo Paula Vieira; Silke Meiners; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.

Authors:  Moumita Ghosh; York E Miller; Ichiro Nakachi; Jennifer B Kwon; Anna E Barón; Alexandra E Brantley; Daniel T Merrick; Wilbur A Franklin; Robert L Keith; R William Vandivier
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

5.  Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease.

Authors:  Moumita Ghosh; York E Miller; R William Vandivier
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

6.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

7.  GPR40 receptor activation promotes tight junction assembly in airway epithelial cells via AMPK-dependent mechanisms.

Authors:  Aekkacha Moonwiriyakit; Panisara Wattanaphichet; Varanuj Chatsudthipong; Chatchai Muanprasat
Journal:  Tissue Barriers       Date:  2018-08-29

8.  Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke.

Authors:  Gimano D Amatngalim; Jasmijn A Schrumpf; Almira Henic; Esther Dronkers; Renate M Verhoosel; Soledad R Ordonez; Henk P Haagsman; Maria E Fuentes; Sriram Sridhar; Jamil Aarbiou; Richard A J Janssen; Annemarie N Lekkerkerker; Pieter S Hiemstra
Journal:  J Innate Immun       Date:  2017-02-08       Impact factor: 7.349

Review 9.  The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.

Authors:  Koshika Yadava; Paul Bollyky; Melissa A Lawson
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

Review 10.  Advances in Chronic Obstructive Pulmonary Disease.

Authors:  Michael C Ferrera; Wassim W Labaki; MeiLan K Han
Journal:  Annu Rev Med       Date:  2021-01-27       Impact factor: 13.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.